Mehra Anand
Insider CIK 1590102 · ALIM 10% owner · MRNS Director, 10% owner · AERI Director, 10% owner · LIFE 10% owner · HSGX 10% owner · PRNB 10% owner · VSAR 10% owner · MIRN 10% owner · ACRS Director, 10% owner · GRTX 10% owner · ONCE Director · MRUS Director · ITRM 10% owner · NXTC 10% owner · ETTX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2026-06-05 | 2026-06-08 | 11,580 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2026-06-05 | 2026-06-08 | 11,580 | — | $0 | 726,403 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 42,350 | — | $0 | 42,350 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 10,987 | — | $0 | 10,987 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 8,631 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 6,120 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 16,604 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 14,414 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 8,844 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 13,193 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 8,500 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 4,983 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 5,650 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 17,000 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-06-06 | 2025-06-09 | 4,793 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-06-06 | 2025-06-09 | 4,793 | — | $0 | 714,823 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 11,580 | — | $0 | 11,580 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 42,350 | — | $0 | 42,350 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2025-05-22 | 2025-05-27 | 13,193 | — | $0 | 13,193 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2024-11-19 | 2024-11-20 | 666,666 | $2.25 | $1.50M | 710,030 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 4,793 | — | $0 | 4,793 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 15,750 | — | $0 | 15,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-06-01 | 2024-06-04 | 4,660 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-06-01 | 2024-06-04 | 4,660 | — | $0 | 43,364 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2024-05-07 | 2024-05-09 | 8,844 | — | $0 | 8,844 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2023-06-08 | 2023-06-12 | 14,414 | — | $0 | 14,414 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-06-02 | 2023-06-05 | 4,507 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-06-02 | 2023-06-05 | 4,507 | — | $0 | 38,704 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 4,660 | — | $0 | 4,660 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 15,750 | — | $0 | 15,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-06-03 | 2022-06-06 | 3,356 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-06-03 | 2022-06-06 | 3,356 | — | $0 | 34,197 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 4,507 | — | $0 | 4,507 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 15,750 | — | $0 | 15,750 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2022-05-31 | 2022-06-02 | 16,604 | — | $0 | 16,604 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-06-03 | 2021-06-04 | 12,250 | — | $0 | 12,250 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-06-03 | 2021-06-04 | 3,356 | — | $0 | 3,356 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2021-05-28 | 2021-06-02 | 6,120 | — | $0 | 6,120 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-02-02 | 2021-02-03 | 8,000 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-02-02 | 2021-02-03 | 6,632 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-02-02 | 2021-02-03 | 6,632 | $18.32 | $121.5K | 30,841 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-02-02 | 2021-02-03 | 8,000 | $18.35 | $146.8K | 24,209 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2020-06-30 | 2020-07-02 | 8,631 | — | $0 | 8,631 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-06-06 | 2020-06-08 | 7,333 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-06-06 | 2020-06-08 | 7,333 | — | $0 | 16,209 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-06-04 | 2020-06-08 | 16,500 | — | $0 | 16,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-03-02 | 2020-03-04 | 8,876 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 8,876 | — | $0 | 8,876 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-03-02 | 2020-03-04 | 8,876 | — | $0 | 8,876 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | D To issuer deriv | 2019-12-17 | 2019-12-17 | 4,000 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | D To issuer deriv | 2019-12-17 | 2019-12-17 | 6,000 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | D To issuer deriv | 2019-12-17 | 2019-12-17 | 4,000 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | U Tender | 2019-12-17 | 2019-12-17 | 481,270 | $114.50 | $55.11M | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | U Tender | 2019-12-17 | 2019-12-17 | 40,203 | $114.50 | $4.60M | 0 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2019-11-15 | 2019-11-19 | 150,000 | $36.75 | $5.51M | 2,671,856 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 9,090,909 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 2,709,659 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | P Buy | 2019-11-12 | 2019-11-12 | 750,000 | $12.00 | $9.00M | 3,083,712 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2019-11-12 | 2019-11-12 | 2,333,712 | — | $0 | 2,333,712 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 7,333 | — | $0 | 7,333 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2019-05-30 | 2019-06-03 | 1,500 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2019-05-30 | 2019-06-03 | 1,500 | — | $0 | 40,203 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 3,773,585 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 7,301,000 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 3,732,500 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 2,239,500 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 464,599 | — | $0 | 743,358 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 908,785 | — | $0 | 1,652,143 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 469,713 | — | $0 | 2,121,856 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 278,759 | — | $0 | 278,759 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2019-05-13 | 2019-05-15 | 400,000 | $15.00 | $6.00M | 2,521,856 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2019-01-04 | 2019-01-08 | 37,203 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2019-01-04 | 2019-01-08 | 37,203 | $3.45 | $128.4K | 38,703 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2018-10-22 | 2018-10-23 | 372,093 | $10.75 | $4.00M | 1,911,573 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 7,446,904 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 9,502,249 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 359,267 | — | $0 | 359,267 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | P Buy | 2018-09-28 | 2018-10-02 | 337,724 | $15.00 | $5.07M | 1,180,178 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 458,425 | — | $0 | 842,454 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 453,954 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 625,482 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 521,235 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 167,537 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 625,482 | — | $0 | 625,482 | SEC↗ |
| PRNB Principia Biopharma Inc. | P Buy | 2018-09-18 | 2018-09-20 | 270,000 | $17.00 | $4.59M | 2,038,208 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 167,537 | — | $0 | 1,768,208 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 453,954 | — | $0 | 1,600,671 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 521,235 | — | $0 | 1,146,717 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2018-06-07 | 2018-06-08 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2018-05-31 | 2018-06-01 | 1,500 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2018-05-31 | 2018-06-01 | 1,500 | — | $0 | 1,500 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 721,408 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 229,660 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 275,446 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2018-05-30 | 2018-06-01 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2018-05-30 | 2018-06-01 | 1,500 | — | $0 | 1,500 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-30 | 500,000 | $13.00 | $6.50M | 1,726,514 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 721,408 | — | $0 | 721,408 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 229,660 | — | $0 | 1,226,514 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 275,446 | — | $0 | 996,854 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-07-24 | 2017-07-26 | 518 | $73.10 | $37.9K | 481,270 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-07-24 | 2017-07-26 | 7,350 | $71.59 | $526.2K | 486,467 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-07-24 | 2017-07-26 | 199,311 | $70.04 | $13.96M | 493,817 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-07-24 | 2017-07-26 | 4,679 | $72.28 | $338.2K | 481,788 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-06-21 | 2017-06-22 | 5,282 | $65.00 | $343.3K | 693,128 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-06-20 | 2017-06-22 | 1,020 | $65.00 | $66.3K | 698,410 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2017-06-15 | 2017-06-16 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2017-05-31 | 2017-06-02 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2017-05-31 | 2017-06-02 | 1,500 | — | $0 | 1,500 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-03-02 | 2017-03-06 | 15,275 | $65.01 | $993.0K | 699,430 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-03-01 | 2017-03-01 | 17,470 | $65.01 | $1.14M | 714,705 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-02-28 | 2017-03-01 | 25,274 | $65.02 | $1.64M | 732,175 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-02-27 | 2017-03-01 | 41,910 | $65.02 | $2.72M | 757,449 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-02-17 | 2017-02-22 | 7,535 | $65.01 | $489.9K | 799,359 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-02-16 | 2017-02-16 | 2,900 | $65.01 | $188.5K | 806,894 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-02-15 | 2017-02-16 | 31,497 | $65.03 | $2.05M | 809,794 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-02-14 | 2017-02-16 | 950 | $65.02 | $61.8K | 841,291 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-02-09 | 2017-02-13 | 37,411 | $65.06 | $2.43M | 842,241 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-02-07 | 2017-02-07 | 1,994 | $65.04 | $129.7K | 879,652 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-02-06 | 2017-02-07 | 1,010 | $65.00 | $65.7K | 881,646 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2017-02-03 | 2017-02-07 | 22,330 | $65.06 | $1.45M | 882,656 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2017-01-10 | 2017-01-12 | 750,000 | $28.25 | $21.19M | 1,539,480 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-12-16 | 2016-12-19 | 229,728 | $53.26 | $12.24M | 954,986 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-12-16 | 2016-12-19 | 50,000 | $54.91 | $2.75M | 904,986 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-12-15 | 2016-12-19 | 69,928 | $53.07 | $3.71M | 1,184,714 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-12-13 | 2016-12-13 | 22,281 | $53.32 | $1.19M | 1,254,642 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-12-09 | 2016-12-13 | 22,113 | $55.27 | $1.22M | 1,321,663 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-12-09 | 2016-12-13 | 33,840 | $57.24 | $1.94M | 1,276,923 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-12-09 | 2016-12-13 | 10,900 | $56.55 | $616.4K | 1,310,763 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-12-09 | 2016-12-13 | 24,498 | $54.03 | $1.32M | 1,343,776 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-12-09 | 2016-12-13 | 8,900 | $53.07 | $472.3K | 1,368,274 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2016-10-20 | 2016-10-24 | 724,788 | $1.39 | $1.01M | 1,134,851 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2016-10-20 | 2016-10-24 | 12,528 | $1.39 | $17.4K | 15,470 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2016-10-20 | 2016-10-24 | 13,367 | $1.39 | $18.6K | 224,845 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-08-11 | 2016-08-12 | 500 | $61.48 | $30.7K | 1,377,174 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-08-11 | 2016-08-12 | 22,563 | $60.14 | $1.36M | 1,377,674 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-08-10 | 2016-08-12 | 6,900 | $60.02 | $414.1K | 1,400,237 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-08-08 | 2016-08-10 | 100 | $60.47 | $6.0K | 1,407,137 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-08-04 | 2016-08-05 | 452 | $60.00 | $27.1K | 1,407,237 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2016-08-03 | 2016-08-05 | 3,300 | — | $0 | 3,300 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2016-08-03 | 2016-08-05 | 7,700 | — | $0 | 7,700 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-08-03 | 2016-08-05 | 4,612 | $60.00 | $276.7K | 1,407,689 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-08-01 | 2016-08-03 | 22,665 | $60.03 | $1.36M | 1,412,301 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2016-06-29 | 2016-07-01 | 6,632 | — | $0 | 6,632 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2016-06-01 | 2016-06-03 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-05-31 | 2016-06-02 | 500 | $60.00 | $30.0K | 1,434,966 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2015-11-27 | 2015-11-30 | 5,350 | $60.02 | $321.1K | 1,435,466 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2015-11-25 | 2015-11-30 | 17,611 | $60.01 | $1.06M | 1,440,816 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2015-11-12 | 2015-11-12 | 1,074 | $60.00 | $64.4K | 1,458,427 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2015-11-11 | 2015-11-12 | 97,644 | $60.13 | $5.87M | 1,459,501 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2015-11-10 | 2015-11-12 | 5,932 | $60.01 | $356.0K | 1,557,145 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2015-11-09 | 2015-11-12 | 25,955 | $60.07 | $1.56M | 1,563,077 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 2,000,000 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 2,063,107 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 2,424,242 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2015-10-13 | 2015-10-13 | 409,090 | $11.00 | $4.50M | 2,289,480 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion | 2015-10-13 | 2015-10-13 | 1,880,390 | — | $0 | 1,880,390 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2015-10-08 | 2015-10-09 | 11,316 | $46.38 | $524.8K | 1,589,032 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2015-10-08 | 2015-10-09 | 120,593 | $44.38 | $5.35M | 1,746,071 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2015-10-08 | 2015-10-09 | 145,723 | $45.27 | $6.60M | 1,600,348 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2015-10-07 | 2015-10-09 | 13,402 | $47.14 | $631.8K | 1,866,664 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2015-10-07 | 2015-10-09 | 153,008 | $46.23 | $7.07M | 1,880,066 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2015-10-07 | 2015-10-09 | 85,502 | $45.56 | $3.90M | 2,033,074 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | P Buy | 2015-10-06 | 2015-10-06 | 857,142 | $7.00 | $6.00M | 2,974,811 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-06 | 289,841 | — | $0 | 2,117,669 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion deriv | 2015-10-05 | 2015-10-06 | 583,559 | — | $0 | 0 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion deriv | 2015-10-05 | 2015-10-06 | 1,244,269 | — | $0 | 0 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion | 2015-10-05 | 2015-10-06 | 1,244,269 | — | $0 | 1,244,269 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion | 2015-10-05 | 2015-10-06 | 583,559 | — | $0 | 1,827,828 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2015-07-20 | 2015-07-22 | 6,300 | — | $0 | 6,300 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 14,968,722 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-14 | 1,546,126 | — | $0 | 1,546,126 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2015-05-12 | 2015-05-14 | 320,000 | $14.00 | $4.48M | 1,866,126 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2015-04-15 | 2015-04-16 | 294,298 | $33.45 | $9.84M | 469,591 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise deriv | 2015-04-14 | 2015-04-16 | 150,000 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2015-04-14 | 2015-04-16 | 130,702 | $34.08 | $4.45M | 763,889 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise | 2015-04-14 | 2015-04-16 | 150,000 | $5.00 | $750.0K | 916,657 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | J Other | 2015-04-14 | 2015-04-16 | 22,066 | $5.00 | $110.3K | 894,591 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award deriv | 2015-04-10 | 2015-04-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award | 2015-04-10 | 2015-04-14 | 1,700 | — | $0 | 1,700 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2015-02-04 | 2015-02-06 | 30,222 | — | $0 | 1,893,576 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | C Conversion deriv | 2015-02-04 | 2015-02-06 | 1,893,576 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | P Buy | 2015-02-04 | 2015-02-06 | 225,000 | $23.00 | $5.17M | 2,118,576 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | C Conversion | 2015-02-04 | 2015-02-06 | 1,893,576 | — | $0 | 1,893,576 | SEC↗ |
| HSGX HISTOGENICS CORP | X Exercise deriv | 2014-12-08 | 2014-12-10 | 14,569 | — | $0 | 0 | SEC↗ |
| HSGX HISTOGENICS CORP | C Conversion deriv | 2014-12-08 | 2014-12-10 | 960,345 | — | $0 | 0 | SEC↗ |
| HSGX HISTOGENICS CORP | C Conversion deriv | 2014-12-08 | 2014-12-10 | 611,738 | — | $0 | 0 | SEC↗ |
| HSGX HISTOGENICS CORP | C Conversion | 2014-12-08 | 2014-12-10 | 960,345 | — | $0 | 960,345 | SEC↗ |
| HSGX HISTOGENICS CORP | X Exercise | 2014-12-08 | 2014-12-10 | 14,569 | $0.76 | $11.1K | 1,586,652 | SEC↗ |
| HSGX HISTOGENICS CORP | S Sale | 2014-12-08 | 2014-12-10 | 1,002 | $11.00 | $11.0K | 1,585,650 | SEC↗ |
| HSGX HISTOGENICS CORP | P Buy | 2014-12-08 | 2014-12-10 | 500,198 | $11.00 | $5.50M | 2,085,848 | SEC↗ |
| HSGX HISTOGENICS CORP | J Other | 2014-12-08 | 2014-12-10 | 8,808 | — | $0 | 2,077,040 | SEC↗ |
| HSGX HISTOGENICS CORP | C Conversion | 2014-12-08 | 2014-12-10 | 611,738 | — | $0 | 1,572,083 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2014-11-25 | 2014-11-26 | 800,000 | $26.00 | $20.80M | 766,657 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2014-09-30 | 2014-10-01 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | J Other | 2014-09-12 | 2014-09-15 | 2,000,000 | — | $0 | 506,270 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | J Other | 2014-09-12 | 2014-09-15 | 40,020 | — | $0 | 40,020 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion deriv | 2014-09-11 | 2014-09-15 | 166,667 | — | $0 | 83,333 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion | 2014-09-11 | 2014-09-15 | 2,506,270 | $2.66 | $6.67M | 2,506,270 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | J Other deriv | 2014-08-05 | 2014-08-07 | 524,734 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 28,156 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 636,393 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 2,065,553 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 28,612 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 415,857 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 2,098,937 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 43,785 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | J Other deriv | 2014-08-05 | 2014-08-07 | 103,964 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | J Other deriv | 2014-08-05 | 2014-08-07 | 7,153 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 3,212,038 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 409,241 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 494,161 | — | $0 | 494,161 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 6,736 | — | $0 | 6,736 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 322,913 | — | $0 | 817,074 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 63,978 | — | $0 | 161,885 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 4,402 | — | $0 | 11,138 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 317,777 | — | $0 | 1,134,851 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 62,960 | — | $0 | 224,845 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 4,332 | — | $0 | 15,470 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | P Buy | 2014-08-05 | 2014-08-07 | 724,788 | $8.00 | $5.80M | 1,859,639 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | P Buy | 2014-08-05 | 2014-08-07 | 13,367 | $8.00 | $106.9K | 238,212 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | P Buy | 2014-08-05 | 2014-08-07 | 12,528 | $8.00 | $100.2K | 27,998 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 97,907 | — | $0 | 97,907 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2014-07-10 | 2014-07-11 | 8,022 | $25.81 | $207.0K | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2014-07-09 | 2014-07-11 | 1,000,000 | $24.00 | $24.00M | 1,566,657 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award deriv | 2014-06-11 | 2014-06-16 | 13,500 | — | $0 | 13,500 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | J Other | 2014-06-02 | 2014-06-04 | 200,000 | — | $0 | 2,566,657 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | J Other | 2014-06-02 | 2014-06-04 | 8,022 | — | $0 | 8,022 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2014-05-22 | 2014-05-27 | 323,932 | $16.00 | $5.18M | 2,766,657 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-26 | 2014-03-28 | 775,315 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-26 | 2014-03-28 | 802,596 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-26 | 2014-03-28 | 485,664 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-26 | 2014-03-28 | 23,403 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-26 | 2014-03-28 | 485,664 | — | $0 | 2,086,978 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2014-03-26 | 2014-03-28 | 60,000 | $21.00 | $1.26M | 2,146,978 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-26 | 2014-03-28 | 23,403 | — | $0 | 23,403 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-26 | 2014-03-28 | 775,315 | — | $0 | 798,718 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-26 | 2014-03-28 | 802,596 | — | $0 | 1,601,314 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-30 | 6,818,182 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-30 | 353,800 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-30 | 778,000 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-30 | 750,000 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-30 | 4,662,765 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-30 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2013-10-25 | 2013-10-30 | 285,000 | $10.00 | $2.85M | 3,090,589 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-25 | 2013-10-30 | 932,553 | — | $0 | 932,553 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-25 | 2013-10-30 | 1,363,636 | — | $0 | 2,296,189 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-25 | 2013-10-30 | 353,800 | — | $0 | 2,805,589 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-25 | 2013-10-30 | 155,600 | $0.05 | $7.8K | 2,451,789 | SEC↗ |